134 related articles for article (PubMed ID: 8929247)
1. Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.
Schall R; Müller FO; Duursema L; Groenewoud G; Hundt HK; Middle MV; Mogilnicka EM; Swart KJ
Arzneimittelforschung; 1995 Nov; 45(11):1236-9. PubMed ID: 8929247
[TBL] [Abstract][Full Text] [Related]
2. [Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].
Loos U; Musch E; Schwabe HK
Pneumologie; 1990 Feb; 44 Suppl 1():488-9. PubMed ID: 2367445
[TBL] [Abstract][Full Text] [Related]
3. Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. I. Single-dose study.
Acocella G; Nonis A; Gialdroni-Grassi G; Grassi C
Am Rev Respir Dis; 1988 Oct; 138(4):882-5. PubMed ID: 3202464
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
BMC Infect Dis; 2015 Mar; 15():126. PubMed ID: 25887748
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study.
Acocella G; Nonis A; Perna G; Patane E; Gialdroni-Grassi G; Grassi C
Am Rev Respir Dis; 1988 Oct; 138(4):886-90. PubMed ID: 3202465
[TBL] [Abstract][Full Text] [Related]
6. [Isoprodian in combination with ethambutol and rifampicin in the treatment of tuberculosis (author's transl)].
Hoose C
Prax Pneumol; 1975 Sep; 29(9):517-9. PubMed ID: 1208336
[No Abstract] [Full Text] [Related]
7. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
Grumbach F
Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
[No Abstract] [Full Text] [Related]
8. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis.
Garg SK; Dhand R; Malik SK; Kalra S; Gupta PH; Jha VK; Shukla VK; Lal R
Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):417-20. PubMed ID: 3220617
[TBL] [Abstract][Full Text] [Related]
9. [Absorption of anti-tuberculous drugs after gastric surgery (author's transl)].
Kleber FX
Prax Klin Pneumol; 1979 Jan; 33(1):38-44. PubMed ID: 760100
[TBL] [Abstract][Full Text] [Related]
10. A novel solid dosage form of rifampicin and isoniazid with improved functionality.
Gohel MC; Sarvaiya KG
AAPS PharmSciTech; 2007 Aug; 8(3):E68. PubMed ID: 17915818
[TBL] [Abstract][Full Text] [Related]
11. [Intravenous rifampicin therapy in open tuberculosis].
Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; Schwabe HK; Hengstmann J; Eichelbaum M
Med Welt; 1983 Jun; 34(24):701-3. PubMed ID: 6888237
[No Abstract] [Full Text] [Related]
12. Bioavailability of rifampicin capsules.
Buniva G; Pagani V; Carozzi A
Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):404-9. PubMed ID: 6688798
[TBL] [Abstract][Full Text] [Related]
13. [Treatment modalities applied to tuberculosis patients in a French department. Hautes-Pyrénées, 1973 to 1980].
Hetrick G; Humarau H
Rev Fr Mal Respir; 1983; 11(6):883-7. PubMed ID: 6669799
[TBL] [Abstract][Full Text] [Related]
14. [Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol].
Skakun NP; Tabachuk OE
Probl Tuberk; 1991; (10):77-9. PubMed ID: 1788241
[TBL] [Abstract][Full Text] [Related]
15. Ethambutol plus isoniazid compared with rifampicin plus isoniazid in antituberculosis continuation treatment.
Lees AW; Allan GW; Smith J; Tyrrell WF
Lancet; 1977 Jun; 1(8024):1232-3. PubMed ID: 68331
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of antituberculosis drugs in patients.
Israili ZH; Rogers CM; el-Attar H
J Clin Pharmacol; 1987 Jan; 27(1):78-83. PubMed ID: 3680559
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients].
Koriakin VA; Sokolova GB; Ziia AV; Zeliger LR; Ivleva AIa
Ter Arkh; 1987; 59(7):75-7. PubMed ID: 3672366
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin].
Pilheu JA; Galati MR; Yunis AS; De Salvo MC; Negroni R; García Fernández JC; Mingolla L; Rubio MC; Masana M; Acevedo C
Medicina (B Aires); 1989; 49(1):43-7. PubMed ID: 2698437
[TBL] [Abstract][Full Text] [Related]
19. [Adjusting or not adjusting isoniazid dosage?].
Parrot R; Boval C; Grosset J; Gaillard JP
Rev Fr Mal Respir; 1983; 11(5):705-12. PubMed ID: 6658156
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations and bioavailability of rifampicin and isoniazid in combination.
Garnham JC; Taylor T; Turner P; Chasseaud LF
Br J Clin Pharmacol; 1976 Oct; 3(5):897-902. PubMed ID: 973984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
